Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is a cancer of increasing incidence and mortality. Currently, there are no immunohistochemical prognostic markers for RCCs in routine use. The aim of this study was to examine for the first time the immunostaining of myosin VI in RCCs as well as its association...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronkainen, Hanna, Kauppila, Saila, Hirvikoski, Pasi, Vaarala, Markku H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837630/
https://www.ncbi.nlm.nih.gov/pubmed/20074327
http://dx.doi.org/10.1186/1756-9966-29-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837630/
https://www.ncbi.nlm.nih.gov/pubmed/20074327
http://dx.doi.org/10.1186/1756-9966-29-2

Ejemplares similares